Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Fortis EGM on 13...

    Fortis EGM on 13 August over stake sale to IHH

    Written by Ruby Khatun Khatun Published On 2018-07-21T10:15:58+05:30  |  Updated On 21 July 2018 10:15 AM IST
    Fortis EGM on 13 August over stake sale to IHH

    New Delhi: Fortis Healthcare said an extraordinary general meeting (EGM) of the company will be held on 13 August to seek shareholders’ nod for its acquisition by Malaysia’s IHH Healthcare.


    The Fortis Healthcare board had last week approved a Rs4,000-crore offer from IHH Healthcare for a 31.1% stake in it, valuing the cash-strapped firm at Rs8,880 crore. The transaction, to be carried out via IHH Healthcare’s arm Northern TK Venture Pte Ltd, was to be followed up by an open offer for an additional 26% stake in Fortis.


    Read also: IHH Healthcare: Meet the Highest Bidder of Fortis Healthcare


    In a notice for the EGM, Fortis Healthcare said the consent of shareholders is being sought for issuance of 23,52,94,117 equity shares on preferential basis at a price of Rs170 per share aggregating up to Rs4,000 crore to Northern TK Venture Pte Ltd.


    The company is also seeking a nod from shareholders to reclassify Malvinder Mohan Singh, Malvinder Mohan Singh- Trust, Shivinder Mohan Singh, Harpal Singh, Abhishek Singh, Fortis Healthcare Holdings Pvt Ltd, Malav Holdings Pvt Ltd and RHC Holding Pvt Ltd from the ‘promoter and promoter group’ shareholder category to ‘public’ shareholder category.


    The company will also ask shareholders to approve the classification of Northern TK Venture Pte Ltd as ‘promoter’ subsequent to the completion of the preferential allotment of equity shares, Fortis Healthcare said.


    IHH Healthcare is expected to shell out a total of Rs7,300 crore to acquire a 57.1% stake, provided its open offer for 26% stake is fully subscribed. The Malaysian healthcare chain, which will gain majority control of India’s second-largest hospital chain, has already stated that in the long term it will rebrand Fortis hospitals into its own Gleneagles chain.


    Read also: Fortis to be renamed as Gleneagles, says IHH Managing Director Tan See Leng

    Abhishek SinghviAcquisitionapprovalEGMextraordinary general meetingFortisFortis boardFortis HealthcareFortis Healthcare Holdings Pvt LtdFortis HospitalsGleneaglesHarpal SinghIHHIHH HealthcareMalav Holdings Pvt LtdMalvinder Mohan SinghMalvinder Mohan Singh- TrustNorthern TK Venture Pte LtdRHC Holding Pvt LtdshareholdersShivinder Mohan Singhstake sale
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok